Research - Aurora, Colorado, United States
Summit Biolabs is a commercial-stage molecular diagnostics company harnessing the power of liquid-biopsy to rapidly detect diseases like COVID-19, Influenza A/B, bacterial infections, and sexually transmitted diseases.Summit Biolabs was spun out of the University of Colorado Anschutz Medical Campus. The company leveraged its competencies in viral detection in saliva and direct-to-PCR platform technology to help combat the pandemic. Summit developed and deployed two highly accurate, rapid, and high-throughput PCR tests for COVID-19 diagnosis. These commercial laboratory-developed tests eliminate the time and cost of nucleic acid extraction, while significantly improving the turn-around-time for results.Summit Biolabs has ongoing test development projects capitalizing on their direct-to-PCR platform technology for other indications. The company's high-complexity, molecular diagnostics CLIA-certified laboratory is located at Bioscience 3 on the Fitzsimons Innovation Campus in Aurora, Colorado.
reCAPTCHA
Outlook
WordPress.org
Google Font API
Mobile Friendly